arrow
返回
K

Katsuyuki Hotta

Okayama University

52H指数
647论文数
3.1W被引数
收录论文 90
发表时间
ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer modelULK1作为EGFR突变非小细胞肺癌模型中延迟EGFR-TKIs药物耐受的新型治疗靶点
err2026-07-01
err0
PREAI
errMorita, Ayako; Rai, Kammei; Kuribayashi, Tadahiro; Tomida, Shuta; Nishi, Tatsuya; Hara, Naofumi; Makimoto, Go; Ninomiya, Kiichiro; Kubo, Toshio; Ohashi, Kadoaki; Hotta, Katsuyuki; Ochi, Nobuaki; Togashi, Yosuke; Maeda, Yoshinobu; Ichihara, Eiki
err分享
err收藏
TGF-β Inhibitor Potentiates Osimertinib-Induced Anti-Tumor Immunity in Egfr-Mutant Lung CancerTGF-β抑制剂增强Osimertinib诱导的Egfr突变型肺癌抗肿瘤免疫
err2026-02-27
err0
errOAAI
errTadahiro Kuribayashi; Jun Nishimura; Sachi Okawa; Masataka Taoka; Shunta Mori; Takaaki Tanaka; Tomoka Nishimura; Ayako Morita; Naofumi Hara; Kiichiro Ninomiya; Go Makimoto; Kammei Rai; Eiki Ichihara; Katsuyuki Hotta; Yosuke Togashi; Yoshinobu Maeda; Katsuyuki Kiura; Kadoaki Ohashi
err分享
err收藏
Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study非小细胞肺癌早期阿来替尼耐药的临床特征及空间转录组学分析:一项回顾性OLCSG研究
err2026-02-01
err1
PREAI
errKuribayashi, Tadahiro; Makimoto, Go; Ohashi, Kadoaki; Tomida, Shuta; Inoue, Hirofumi; Yokoyama, Toshihide; Kuyama, Shoichi; Kato, Yuka; Kudo, Kenichiro; Horita, Naokatsu; Kayatani, Hiroe; Inoue, Masaaki; Sugimoto, Keisuke; Ninomiya, Kiichiro; Maeda, Yoshinobu; Togashi, Yosuke; Hotta, Katsuyuki
err分享
err收藏
Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial database使用整合的临床试验数据库研究脆弱性对局部晚期非小细胞肺癌患者同步放化疗结局的影响
err2026-01-17
err0
PREAI
errKenji Morimoto; Tadaaki Yamada; Naoya Nishioka; Nobuyuki Yamamoto; Seiji Niho; Isamu Okamoto; Katsuyuki Hotta; Hiroaki Okamoto; Shunichi Sugawara; Toshio Shimokawa; Yuichi Ozawa; Satoshi Oizumi; Koichi Takayama
err分享
err收藏
Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry study日本肺癌患者中静脉血栓栓塞症的发病率和临床特征:CS-Lung-003前瞻性观察性登记研究的结果
err2025-11-01
err0
errOAAI
errTsubata, Yukari; Kanaji, Nobuhiro; Nakao, Mika; Masuda, Takeshi; Yamasaki, Masahiro; Kodani, Masahiro; Ishikawa, Nobuhisa; Kozuki, Toshiyuki; Inoue, Masaaki; Nishii, Kazuya; Hotta, Katsuyuki; Kiura, Katsuyuki; Isobe, Takeshi
err分享
err收藏
Endotracheal and Endobronchial Metastases in Epidermal Growth Factor Receptor Exon 19 Deletion Lung Adenocarcinoma: A Case Successfully Managed with Bronchoscopic Therapy and Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
err2025-10-01
err0
PREAI
errFujiwara, Miho; Baba, Takahiro; Yamada, Kotaro; Nakamura, Eri; Takeguchi, Tetsuya; Takigawa, Yuki; Morita, Ayako; Hara, Naofumi; Watanabe, Hiromi; Ninomiya, Kiichiro; Rai, Kammei; Ichihara, Eiki; Ohashi, Kadoaki; Hotta, Katsuyuki; Sato, Ken; Maeda, Yoshinobu; Togashi, Yosuke; Makimoto, Go
err分享
err收藏
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy抗生素使用对接受免疫检查点抑制剂联合化疗的晚期非小细胞肺癌患者生存的影响
err2025-08-28
err0
PREAI
errNobuaki Ochi; Eiki Ichihara; Toshihide Yokoyama; Koji Inoue; Tomoki Tamura; Hiromi Watanabe; Ichiro Takata; Hirohisa Kano; Kayo Nakamura; Haruyuki Kawai; Masaaki Inoue; Nobukazu Fujimoto; Hirohisa Ichikawa; Chihiro Ando; Isao Oze; Nagio Takigawa; Yoshinobu Maeda; Katsuyuki Hotta
err分享
err收藏
Durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: outcomes in age, sex, and platinum subgroups from the phase 3 CASPIAN study度伐利尤单抗联合铂类-依托泊苷治疗广泛期小细胞肺癌:CASPIAN III期研究中不同年龄、性别和铂类亚组的结果
err2025-08-05
err0
errOAAI
errNiels Reinmuth; Jonathan W. Goldman; Yuanbin Chen; Katsuyuki Hotta; Dmytro Trukhin; Galina Statsenko; Maximilian Hochmair; Mustafa Özgüroğlu; Jun Ho Ji; Marina Chiara Garassino; Artem Poltoratskiy; Francesco Verderame; Libor Havel; Igor Bondarenko; György Losonczy; Nikolay Conev; Shannon Kummer; Helen Mann; Priti Chugh; Tapashi Dalvi; Luis Paz-Ares
err分享
err收藏
Phase-Ib dose-finding and pharmacokinetic trial of metformin combined with nivolumab for refractory/recurrent solid tumorsPhase-Ib剂量探索和药代动力学试验:二甲双胍联合nivolumab治疗难治性/复发性实体瘤
err2025-05-28
err0
errOAAI
errKubo, Toshio; Kato, Hironari; Horiguchi, Shigeru; Kozuki, Toshiyuki; Asagi, Akinori; Yoshida, Michihiro; Udono, Heiichiro; Kiura, Katsuyuki; Hotta, Katsuyuki
err分享
err收藏
Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study吉非替尼诱导联合化放疗在EGFR突变型III期非小细胞肺癌中的五年结果:LOGIK0902/OLCSG0905 II期研究
err2025-02-05
err0
errOAAI
errHotta, Katsuyuki; Saeki, Sho; Sakata, Shinya; Yamaguchi, Masafumi; Harada, Daijiro; Bessho, Akihiro; Tanaka, Kentaro; Inoue, Koji; Inoue, Koji; Gemba, Kenichi; Kubo, Toshio; Sato, Akiko; Ichihara, Eiki; Watanabe, Hiromi; Kishimoto, Junji; Shioyama, Yoshiyuki; Katsui, Kuniaki; Sugio, Kenji; Kiura, Katsuyuki
err分享
err收藏
Association between skin toxicity and ef fi cacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM
err2024-04-01
err0
errOAAI
errWatanabe, S.; Yoshioka, H.; Sakai, H.; Hotta, K.; Takenoyama, M.; Yamada, K.; Sugawara, S.; Takiguchi, Y.; Hosomi, Y.; Tomii, K.; Niho, S.; Nishio, M.; Kato, T.; Takahashi, T.; Ebi, H.; Aono, M.; Yamamoto, N.; Ohe, Y.; Nakagawa, K.
err分享
err收藏
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer
err2024-01-09
err5
PREAI
errMorita, Ayako; Ichihara, Eiki; Inoue, Koji; Fujiwara, Keiichi; Yokoyama, Toshihide; Harada, Daijiro; Ando, Chihiro; Kano, Hirohisa; Oda, Naohiro; Tamura, Tomoki; Ochi, Nobuaki; Kawai, Haruyuki; Inoue, Masaaki; Hara, Naofumi; Fujimoto, Nobukazu; Ichikawa, Hirohisa; Oze, Isao; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki
err分享
err收藏
Phase-Ib trial of metformin combined with nivolumab for refractory/recurrent solid tumors
err2023-10-01
err0
errOAAI
errKubo, T.; Kato, H.; Horiguchi, S.; Ninomiya, T.; Kozuki, T.; Asagi, A.; Takamoto, A.; Umeda, Y.; Kamikawa, K.; Yoshida, M.; Udono, U.; Hotta, K.; Maeda, Y.; Kiura, K.
err分享
err收藏
CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
err2023-10-01
err2
errOAAI
errHara, Naofumi; Ichihara, Eiki; Kano, Hirohisa; Ando, Chihiro; Morita, Ayako; Nishi, Tatsuya; Okawa, Sachi; Nakasuka, Takamasa; Hirabae, Atsuko; Abe, Masaya; Asada, Noboru; Ninomiya, Kiichiro; Makimoto, Go; Fujii, Masanori; Kubo, Toshio; Ohashi, Kadoaki; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki
err分享
err收藏
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report
err2022-06-01
err32
errOAAI
errChen, Yuanbin; Paz-Ares, Luis; Reinmuth, Niels; Garassino, Marina Chiara; Statsenko, Galina; Hochmair, Maximilian J.; Oezgueroglu, Mustafa; Verderame, Francesco; Havel, Libor; Losonczy, Gyorgy; Conev, Nikolay, V; Hotta, Katsuyuki; Ji, Jun Ho; Spencer, Stuart; Dalvi, Tapashi; Jiang, Haiyi; Goldman, Jonathan W.
err分享
err收藏
Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIANDurvalumab,联合或不联合tremelimumab,联合铂类依托泊苷一线治疗广泛期小细胞肺癌: 来自里海的3年总生存率更新
err2022-04-01
err160
errOAAI
errPaz-Ares, L.; Chen, Y.; Reinmuth, N.; Hotta, K.; Trukhin, D.; Statsenko, G.; Hochmair, M. J.; Ozguroglu, M.; Ji, J. H.; Garassino, M. C.; Voitko, O.; Poltoratskiy, A.; Musso, E.; Havel, L.; Bondarenko, I; Losonczy, G.; Conev, N.; Mann, H.; Dalvi, T. B.; Jiang, H.; Goldman, J. W.
err分享
err收藏
First-line nivolumab plus ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patientsnivolumab联合ipilimumab一线治疗晚期NSCLC: 亚洲患者CheckMate 227亚群分析
err2022-02-01
err13
errOAAI
errO'Byrne, K. J.; Lee, K. H.; Kim, S-W; Park, K.; Nishio, M.; Sakai, H.; Ohe, Y.; Fukuhara, T.; Kang, J-H; Daga, H.; Yu, C-J; Hotta, K.; Tanaka, H.; Takeda, M.; Yokoyama, T.; Nathan, F. E.; Lee, J-S
err分享
err收藏
Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression对letter re的回应: 抗生素对非小细胞肺癌患者免疫检查点抑制剂疗效的影响因PD-L1表达而异
err2021-11-01
err0
PREAI
errOchi, Nobuaki; Ichihara, Eiki; Takigawa, Nagio; Harada, Daijiro; Inoue, Koji; Shibayama, Takuo; Hosokawa, Shinobu; Kishino, Daizo; Harita, Shingo; Oda, Naohiro; Hara, Naofumi; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki
err分享
err收藏